| Window | Theses | Resolved | Wins | Win rate | Avg return | Median return |
|---|---|---|---|---|---|---|
| 1d | — | — | — | — | — | — |
| 3d | — | — | — | — | — | — |
| 1w | — | — | — | — | — | — |
| 1m | — | — | — | — | — | — |
| 3m | — | — | — | — | — | — |
| 6m | — | — | — | — | — | — |
| 1y | — | — | — | — | — | — |
Past performance does not predict future results. Informational only, not investment advice.
CBOE's stock declined initially alongside CME's announcement but has recovered to an 11% gain from the June 22nd entry, indicating a potential buying opportunity as the market digests this competitive threat or opportunity.
CME is launching single-stock futures on July 27, expanding its product offerings. The stock experienced a temporary pullback but has recovered with a 4% gain from the June entry point, suggesting the market is repricing the announcement favorably.
End of results.